Come up with a name for your new list and we'll add to it:
SuviCA raised a round of funding on October 15, 2015. Investors include
National Cancer Institute.
SuviCa is focused on the discovery and development of small molecules for the treatment of cancer. Currently, SuviCa has two small molecule protein synthesis inhibitors in pre-clinical development. SV…